Jian Min Fang
Chief Executive Officer at REMEGEN CO., LTD.
Net worth: 87 M $ as of 2024-04-29
Jian Min Fang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| REMEGEN CO., LTD. | Director/Board Member | 2008-07-03 | - |
| Chief Executive Officer | 2008-07-03 | - | |
| Chief Tech/Sci/R&D Officer | 2008-07-03 | - | |
| Founder | 2008-07-03 | - | |
MabPlex International Co., Ltd.
 MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Founder | 2013-06-24 | - |
| Chairman | 2013-06-24 | - | |
| Chief Executive Officer | 2013-06-24 | 2020-02-29 | |
| Remegen Medical Research Shanghai Co. Ltd. | Director/Board Member | - | - |
| Remegen Biosciences, Inc. | Director/Board Member | - | - |
| Remegen Hong Kong Ltd. | Director/Board Member | - | - |
| Chinese Pharmaceutical Association | Director/Board Member | - | - |
| China Medicinal Biotech Association | Corporate Officer/Principal | - | - |
Career history of Jian Min Fang
Training of Jian Min Fang
| Dalhousie University | Doctorate Degree |
Statistics
International
| China | 6 |
| United States | 2 |
| Hong Kong | 2 |
Operational
| Director/Board Member | 5 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| REMEGEN CO., LTD. | Health Technology |
| Private companies | 6 |
|---|---|
MabPlex International Co., Ltd.
MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |
| Remegen Medical Research Shanghai Co. Ltd. | |
| Remegen Biosciences, Inc. | |
| Remegen Hong Kong Ltd. | |
| Chinese Pharmaceutical Association | |
| China Medicinal Biotech Association |
- Stock Market
- Insiders
- Jian Min Fang
- Experience